Uric Acid and Fructose: Potential Biological Mechanisms

Seminars in Nephrology

Volumn 31, Issue 5, 2011, Pages 426-432

  Lanaspa, Miguel A ^a   Tapia, Edilia ^b   Soto, Virgilia ^c   Sautin, Yuri ^d   Sánchez Lozada, Laura Gabriela ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Fructose; Hyperuricemia; Metabolic syndrome; Oxidative stress; Renal damage

Indexed keywords

ADENOSINE PHOSPHATE; ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN II; ENDOTHELIN 1; FRUCTOSE; GLUCOSE TRANSPORTER; GLUT 2 PROTEIN; GLUT 5 PROTEIN; GLYCERALDEHYDE; GLYCOGEN; INOSINE PHOSPHATE; INSULIN; MEMBRANE PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URATE OXIDASE; URIC ACID;

ARTICLE; DEPHOSPHORYLATION; FATTY ACID OXIDATION; FOOD INTAKE; FRUCTOSE DEPHOSPHORYLATION; FRUCTOSE METABOLISM; FRUCTOSE PHOSPHORYLATION; GLYCOGEN LIVER LEVEL; HUMAN; HYPERINSULINEMIA; HYPERURICEMIA; KIDNEY ARTERY VASOCONSTRICTION; KIDNEY BLOOD VESSEL; LIPID STORAGE; LIPOGENESIS; LIVER METABOLISM; METABOLIC SYNDROME X; NATRIURESIS; NEPHRON; NONHUMAN; OXIDATIVE STRESS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURINE METABOLISM; VASOCONSTRICTION;

ANIMALS; FRUCTOSE; HUMANS; HYPERURICEMIA; URIC ACID;

EID: 80054055459     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2011.08.006     Document Type: Article

References (47)

1. Tappy L., Le K.A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010, 90:23-46.
2. Jalal D.I., Smits G., Johnson R.J., Chonchol M. Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 2010, 21:1543-1549.
3. Hallfrisch J. Metabolic effects of dietary fructose. FASEB J 1990, 4:2652-2660.
4. Le G.M., Tobin V., Stolarczyk E., Dalet V., Leturque A., Brot-Laroche E. Sugar sensing by enterocytes combines polarity, membrane bound detectors and sugar metabolism. J Cell Physiol 2007, 213:834-843.
5. Nakayama T., Kosugi T., Gersch M., Connor T., Sanchez-Lozada L.G., Lanaspa M.A., et al. Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am J Physiol Renal Physiol 2010, 298:F712-F720.
6. Diggle C.P., Shires M., Leitch D., Brooke D., Carr I.M., Markham A.F., et al. Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme. J Histochem Cytochem 2009, 57:763-774.
7. Asipu A., Hayward B.E., O'Reilly J., Bonthron D.T. Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. Diabetes 2003, 52:2426-2432.
8. Leturque A., Brot-Laroche E., Le G.M. GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab 2009, 296:E985-E992.
9. Johnson R.J., Perez-Pozo S.E., Sautin Y.Y., Manitius J., Sanchez-Lozada L.G., Feig D.I., et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?. Endocr Rev 2009, 30:96-116.
10. Petersen A., Kappler F., Szwergold B.S., Brown T.R. Fructose metabolism in the human erythrocyte. Phosphorylation to fructose 3-phosphate. Biochem J 1992, 284:363-366.
11. Lim J.S., Mietus-Snyder M., Valente A., Schwarz J.M., Lustig R.H. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 2010, 7:?>251-64.
12. Dekker M.J., Su Q., Baker C., Rutledge A.C., Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010, 299:E685-E694.
13. Stormon M.O., Cutz E., Furuya K., Bedford M., Yerkes L., Tolan D.R., et al. A six-month-old infant with liver steatosis. J Pediatr 2004, 144:258-263.
14. Ali M., Rellos P., Cox T.M. Hereditary fructose intolerance. J Med Genet 1998, 35:353-365.
15. Schalkwijk C.G., Stehouwer C.D., van Hinsbergh V.W. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification. Diabetes Metab Res Rev 2004, 20:369-382.
16. Concha I.I., Velasquez F.V., Martinez J.M., Angulo C., Droppelmann A., Reyes A.M., et al. Human erythrocytes express GLUT5 and transport fructose. Blood 1997, 89:4190-4195.
17. Wang X., Jia X., Chang T., Desai K., Wu L. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats. J Hypertens 2008, 26:765-772.
18. Tran L.T., Yuen V.G., McNeill J.H. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem 2009, 332:145-159.
19. Tran L.T., Macleod K.M., McNeill J.H. Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats. Mol Cell Biochem 2009, 325:89-97.
20. Nagai Y., Ichihara A., Nakano D., Kimura S., Pelisch N., Fujisawa Y., et al. Possible contribution of the non-proteolytic activation of prorenin to the development of insulin resistance in fructose-fed rats. Exp Physiol 2009, 94:1016-1023.
21. Stanhope K.L., Schwarz J.M., Keim N.L., Griffen S.C., Bremer A.A., Graham J.L., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009, 119:1322-1334.
22. Kizhner T., Werman M.J. Long-term fructose intake: biochemical consequences and altered renal histology in the male rat. Metabolism 2002, 51:1538-1547.
23. Sanchez-Lozada L.G., Tapia E., Jimenez A., Bautista P., Cristobal M., Nepomuceno T., et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 2007, 292:F423-F429.
24. Catena C., Cavarape A., Novello M., Giacchetti G., Sechi L.A. Insulin receptors and renal sodium handling in hypertensive fructose-fed rats. Kidney Int 2003, 64:2163-2171.
25. Vasdev S., Gill V., Parai S., Gadag V. Fructose-induced hypertension in Wistar-Kyoto rats: interaction with moderately high dietary salt. Can J Physiol Pharmacol 2007, 85:413-421.
26. Singh A.K., Amlal H., Haas P.J., Dringenberg U., Fussell S., Barone S.L., et al. Fructose-induced hypertension: essential role of chloride and fructose absorbing transporters PAT1 and Glut5. Kidney Int 2008, 74:438-447.
27. Bomback A.S., Derebail V.K., Shoham D.A., Anderson C.A., Steffen L.M., Rosamond W.D., et al. Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int 2010, 77:609-616.
28. Nguyen S., Choi H.K., Lustig R.H., Hsu C.Y. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr 2009, 154:807-813.
29. Gao X., Qi L., Qiao N., Choi H.K., Curhan G., Tucker K.L., et al. Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension 2007, 50:306-312.
30. Choi J.W., Ford E.S., Gao X., Choi H.K. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008, 59:109-116.
31. Choi H.K., Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008, 336:309-312.
32. Cuspidi C., Valerio C., Sala C., Meani S., Esposito A., Zanchetti A., et al. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Am J Hypertens 2007, 20:678-685.
33. Gonsette R.E., Sindic C., D'hooghe M.B., De Deyn P.P., Medaer R., Michotte A., et al. Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon Beta in Relapsing-Remitting Multiple Sclerosis (ASIIMS) trial. Mult Scler 2010, 16:455-462.
34. Nakagawa T., Hu H., Zharikov S., Tuttle K.R., Short R.A., Glushakova O., et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006, 290:F625-F631.
35. Sanchez-Lozada L.G., Tapia E., Bautista-Garcia P., Soto V., vila-Casado C., Vega-Campos I.P., et al. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2008, 294:F710-F718.
36. Sautin Y.Y., Johnson R.J. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 2008, 27:608-619.
37. Cirillo P., Gersch M.S., Mu W., Scherer P.M., Kim K.M., Gesualdo L., et al. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol 2009, 20:545-553.
38. Kanellis J., Watanabe S., Li J.H., Kang D.H., Li P., Nakagawa T., et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41:1287-1293.
39. Chao H.H., Liu J.C., Lin J.W., Chen C.H., Wu C.H., Cheng T.H. Uric acid stimulates endothelin-1 gene expression associated with NADPH oxidase in human aortic smooth muscle cells. Acta Pharmacol Sin 2008, 29:1301-1312.
40. Yu M.A., Sanchez-Lozada L.G., Johnson R.J., Kang D.H. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010, 28:1234-1242.
41. Sautin Y.Y., Nakagawa T., Zharikov S., Johnson R.J. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007, 293:C584-C596.
42. Cheng T.H., Lin J.W., Chao H.H., Chen Y.L., Chen C.H., Chan P., et al. Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts. Int J Cardiol 2010, 139:42-49.
43. Sanchez-Lozada L.G., Soto V., Tapia E., vila-Casado C., Sautin Y.Y., Nakagawa T., et al. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 2008, 295:F1134-F1141.
44. Khosla U.M., Zharikov S., Finch J.L., Nakagawa T., Roncal C., Mu W., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005, 67:1739-1742.
45. Brown C.M., Dulloo A.G., Yepuri G., Montani J.P. Fructose ingestion acutely elevates blood pressure in healthy young humans. Am J Physiol Regul Integr Comp Physiol 2008, 294:R730-R737.
46. Hu Q.H., Wang C., Li J.M., Zhang D.M., Kong L.D. Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement. Am J Physiol Renal Physiol 2009, 297:F1080-F1091.
47. Oda M., Satta Y., Takenaka O., Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002, 19:640-653.